The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients

ISTH Academy, Faculty / Presenters, 409287

Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism

ISTH Academy, Charlotte Thålin, 405642

Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study

ISTH Academy, Faculty / Presenters, 405643

Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy

ISTH Academy, Faculty / Presenters, 405644

Quality of life in elderly patients with venous thromboembolism assessed using patient-reported outcome measures

ISTH Academy, , 405645

Is intimate partner abuse underestimated as a precipitating factor for venous thromboembolism in women?

ISTH Academy, Faculty / Presenters, 405646

Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome

ISTH Academy, , 405647

Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling

ISTH Academy, Yanyan Xu, 405648

Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy

ISTH Academy, , 405649

Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients

ISTH Academy, , 405650

MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation

ISTH Academy, Frédéric Adam, 405651

APC-PAR1-R46 signaling limits CXCL1 expression during poly IC-induced airway inflammation in mice

ISTH Academy, Silvio Antoniak, 405652

Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis

ISTH Academy, , 409265

Corrigendum to ‘Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children’s Hospital-Acquired Thrombosis Consortium’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139]

ISTH Academy, Faculty / Presenters, 409298

Therapeutic-dose heparin in preventing COVID-19–associated acute kidney injury: What about bleeding risk?

ISTH Academy, , 409297

Artificial intelligence for venous thromboembolism prophylaxis: Clinician perspectives

ISTH Academy, Rushad Patell, 409296

Western blot and immunohistochemical analysis of mouse tissue factor

ISTH Academy, Faculty / Presenters, 409295

COVID-19. Comparison of D-dimer levels measured with 3 commercial platforms

ISTH Academy, Armando Tripodi, 409294

Factor V Leiden interferes with protein S activity assay

ISTH Academy, Agathe Herb, 409293

Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time–based clotting time test results in patients treated with emicizumab

ISTH Academy, Flora Peyvandi, 409292

Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis

ISTH Academy, Faculty / Presenters, 409291

Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis

ISTH Academy, , 409290

Guiding warfarin self-management in children: development of a warfarin nomogram

ISTH Academy, , 409289

Factors XI and XII in extracorporeal membrane oxygenation: longitudinal profile in children

ISTH Academy, Faculty / Presenters, 409288

Issue Information

ISTH Academy, Faculty / Presenters, 409264

Intracardiac thrombi in pediatrics: anticoagulation approach and treatment outcomes

ISTH Academy, Faculty / Presenters, 409286

Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada

ISTH Academy, , 409285

Race, ethnicity, and immune tolerance induction in hemophilia A in the United States

ISTH Academy, Faculty / Presenters, 409284

Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring

ISTH Academy, François Mullier, 409283

Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet–lymphocyte and low platelet–neutrophil aggregates

ISTH Academy, Lucia Stefanini, 409282

Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series

ISTH Academy, Faculty / Presenters, 409281

Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration

ISTH Academy, Radek Kaczmarek, 409280

Antiphospholipid syndrome in rural, remote, and First Nations peoples in the Top End of the Northern Territory, Australia

ISTH Academy, , 409279

Posttraumatic stress disorder and posttraumatic stress symptoms among adults with hemophilia A and B

ISTH Academy, Faculty / Presenters, 409278

Venous thromboembolism among physically active young adult females

ISTH Academy, Anna Gurevich-Shapiro, 409277

D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study

ISTH Academy, Faculty / Presenters, 409276

What can historical literature on von Willebrand disease teach us?

ISTH Academy, Faculty / Presenters, 409275

Immune cell–mediated venous thrombus resolution

ISTH Academy, Faculty / Presenters, 409274

Investigating patients for bleeding disorders when most of the “usual” ones have been ruled out

ISTH Academy, Johanna Gebhart, 409273

Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review

ISTH Academy, , 409272

The crux of menopausal hormone therapy: dose, route, and age

ISTH Academy, Lisa Baumann Kreuziger, 409271

Heavy menstrual bleeding in adolescents: a primary issue in primary care

ISTH Academy, Angela Weyand, 409270

Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details

ISTH Academy, Hanny Al-Samkari, 409269

A need to refine venous thromboembolism risk assessment: the challenge of optimizing patient selection for thromboprophylaxis among hospitalized adults

ISTH Academy, , 409268

Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review

ISTH Academy, Theodore (Ted) Warkentin, 409267

How We Write a Manuscript Discussion

ISTH Academy, Mary Cushman, 409266

Thromboprophylaxis in Surgery for Teenagers

ISTH Academy, Faculty / Presenters, 405141

DOAC Use in Special Populations: A Focus on Obesity and Bariatric Surgery

ISTH Academy, Faculty / Presenters, 400590

RPTH Research Recap Videos

ISTH Academy, Faculty / Presenters, 405288

Breaking the Silence: Addressing Mental Health in Thrombosis Patients

ISTH Academy, Faculty / Presenters, 393956

A Guide to Writing a Successful Grant

ISTH Academy, Faculty / Presenters, 400589

OC 45.4 Crucial Roles of Red Blood Cells and Platelets in Coagulation

ISTH Academy, Faculty / Presenters, 406150

OC 45.3 Major Bleeding Event Rates in Patients on Hemodialysis and Peritoneal Dialysis: Results from the International DOPPS and PDOPPS

ISTH Academy, Faculty / Presenters, 406151

OC 31.4 Novel Factor Xa agents that Restore Hemostasis in Mice Treated with Apixaban

ISTH Academy, Faculty / Presenters, 406152

OC 45.2 Knockdown of Zebrafish Tmem242 Enhances Production of ROS thatSignals to Increase Foxa2 and Foxa3 Expression that May Increase Clotting Factors Resulting in Thrombosis and Bleeding

ISTH Academy, Faculty / Presenters, 406153

OC 45.1 A Genome-Wide CRISPR-Cas9 Knockout Screen Reveals FSP1 as the Warfarin-Resistant Vitamin K Reductase

ISTH Academy, Faculty / Presenters, 406154

OC 73.3 Anticoagulant Properties of Factor V Activation Intermediate (FVai) Functioning as Synergistic TFPI-cofactor with Protein S

ISTH Academy, Faculty / Presenters, 406155

OC 22.5 Effect of Angiostatin and its Neutralization on Cellular Infection by SARS-CoV and SARS-CoV-2

ISTH Academy, Faculty / Presenters, 406156

OC 07.2 Investigating the Dominant Negative Effect of Heterozygous F13B Gene Mutations Detected from Mild FXIII Deficiency Patients

ISTH Academy, Faculty / Presenters, 406281

OC 54.4 Multinational Cohort Analysis of Intracranial Hemorrhage Outcomes in Patients with Brain Tumors Receiving Anticoagulation (ABC Study)

ISTH Academy, Faculty / Presenters, 406420

OC 31.1 Management and Outcomes of Anticoagulated Patients in Urgent Surgery: The PAUSE-ER Study

ISTH Academy, Faculty / Presenters, 406146

OC 51.2 Systematic Immediate Vitamin K Antagonist Reversal with Prothrombin Complex Concentrate in Patients with Recent Mild Traumatic Brain Injury (PREVACT): A Multicenter, Randomized, Controlled Trial

ISTH Academy, Faculty / Presenters, 406145

OC 31.3 Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VMX-C001 in Healthy Subjects

ISTH Academy, Faculty / Presenters, 406144

OC 51.3 Dielectric Blood Coagulometry for Evaluation of Coagulation Activity of Blood Samples from Patients Prescribed with Direct Oral Anticoagulants Undergoing Elective Surgeries

ISTH Academy, Faculty / Presenters, 406143

OC 51.5 Outcomes Associated with the Use of Dual Antiplatelet Therapy in Patients Presenting with out of Hospital Cardiac Arrest Supported with Veno Arterial Extracorporeal Membrane Oxygenation

ISTH Academy, Faculty / Presenters, 406142

OC 51.1 Risk of Delayed Intracranial Hemorrhage According to Antithrombotic Treatment in Patients with Traumatic Brain Injury: Systematic Review and Meta-Analysis

ISTH Academy, Faculty / Presenters, 406141

OC 41.1 Structural Identification of the Factor XII - uPAR Binding Interface for Selective Drug Development

ISTH Academy, Faculty / Presenters, 406140

OC 70.3 Effect of High-Molecular-Weight Kininogen Binding to Factor XI and Prekallikrein on Thrombosis

ISTH Academy, Faculty / Presenters, 406139

OC 70.2 The First Insight into the Spatial Structure of Human Kininogen by Cryogenic Electron Microscopy and Computational Methods

ISTH Academy, Faculty / Presenters, 406138

OC 41.3 Intramolecular Interactions that Stabilize Factor XII in a Closed Form

ISTH Academy, Faculty / Presenters, 406137

OC 41.2 Coagulation Factor XII-Independent Contribution of Kallikrein to Contact Pathway-Mediated Thrombin Generation in Mouse Whole Blood

ISTH Academy, Faculty / Presenters, 406136

OC 70.4 Thrombin Activation of the Factor XI Dimer is a Multi-Staged Process for Each Subunit

ISTH Academy, Faculty / Presenters, 406135

OC 70.1 High Molecular Kininogen Cleavage in Cerebral Malaria

ISTH Academy, Faculty / Presenters, 406134

OC 41.5 Two Positively Charged Patches in the EGF-1 Domain of Factor XII Synergistically Contribute to Surface Binding and Activation

ISTH Academy, Faculty / Presenters, 406133

OC 73.1 Targeted Genetic Disruption of Tissue Factor Pathway Inhibitor (TFPI) Alpha Results in Complete Embryonic Lethality in Mice with Factor V Leiden (FVL)

ISTH Academy, Faculty / Presenters, 406132

OC 45.5 The Lethality in Mice Treated with Intravenous Polyphosphate is Not Due to Thrombosis

ISTH Academy, Faculty / Presenters, 406131

OC 73.2 Cryo-EM Structure of Coagulation Factor V Short

ISTH Academy, Faculty / Presenters, 406130

OC 62.5 Next-Generation, Dendrimer-Like Polyphosphate Inhibitor is a Safe and Effective Antithrombotic Agent

ISTH Academy, Faculty / Presenters, 406129

OC 31.5 Novel Snake Venom Hemocoagulase Reverses Anticoagulant Effect of Factor Xa Inhibitors and Restores Hemostasis In Vitro and In Vivo

ISTH Academy, Faculty / Presenters, 406128

OC 62.4 Factor XI(a) Antibody Abelacimab Reduces Thrombus Growth andPropagation in a Baboon Model of Vascular Graft Thrombosis

ISTH Academy, Faculty / Presenters, 406127

OC 51.4 Low Thrombin Inactivation Capacity is an Independent Risk Factor for Cancer Mortality in Men: Results from the Moli-Sani Study

ISTH Academy, Faculty / Presenters, 406126

OC 31.2 Andexanet Alfa is Associated with Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients with Factor Xa Inhibitor–Related Major Bleeding

ISTH Academy, Faculty / Presenters, 406125

OC 70.5 Coagulation Factor XI Contributes to the Infarct Size and Inflammationin Myocardial Ischemia/Reperfusion Injury

ISTH Academy, Faculty / Presenters, 406124

OC 62.1 Differential Suppression of Arterial Versus Venous Thrombosis but Preserved Hemostasis in Mice Expressing Fibrinogen that Cannot Support Fibrin Formation

ISTH Academy, Faculty / Presenters, 406123

OC 62.3 A Noble Metal Stent Coating Reduces Thrombo-Inflammatory Reactions and Acute Stent Thrombosis – an In Vitro and In Vivo Study

ISTH Academy, Faculty / Presenters, 406122

OC 03.4 A Common, Racially Diverse Protease Activated Receptor 4 Functional Variant Impacts Ischemic Stroke Outcomes: Evidence for a Pharmacogenetic Effect

ISTH Academy, Faculty / Presenters, 406121

OC 03.1 Detailed Assessment of the Microenvironment of Stroke Thrombi Using Imaging Mass Cytometry

ISTH Academy, Faculty / Presenters, 406120

OC 03.5 Arterial Events in Cancer Patients Treated with Apixaban for Venous Thrombosis

ISTH Academy, Faculty / Presenters, 406119

OC 03.3 Effect of Intravenous tPA Treatment on Hemostatic Factors in Relationto Outcome in Acute Ischemic Stroke Patients Undergoing Thrombectomy

ISTH Academy, Faculty / Presenters, 406118

OC 16.4 Thrombin Generation is Associated with Stroke in a General Adult Population: Prospective Findings from the Moli-Sani Study

ISTH Academy, Faculty / Presenters, 406117

OC 03.2 Characterization of Peripheral Monocyte Subsets in a Prospective Cohort of Patients with Acute Stroke Suspicion: Results of BOOST Study

ISTH Academy, Faculty / Presenters, 406116

OC 16.3 Differential Modulation of Platelet Adhesion and Aggregation by Von Willebrand Factor as a New Therapeutic Strategy Against Arterial Thrombosis

ISTH Academy, Faculty / Presenters, 406115

OC 16.5 Rivaroxaban in Combination with Low-Dose Aspirin is Associated with a Reduction in Pro-Inflammatory and Pro-thrombotic Circulating Vesicle Signatures in Patients with Cardiovascular Disease

ISTH Academy, Faculty / Presenters, 406114

OC 16.2 Structural Analyses of Apolipoprotein A-IV Polymorphisms Q360H and T347S Elucidate the Inhibitory Effect Against Thrombosis

ISTH Academy, Faculty / Presenters, 406113

OC 74.4 Prevalence and Predictors of Non-Adherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation, a Historical Cohort Study

ISTH Academy, Faculty / Presenters, 406112

OC 73.4 Patients with Protein C Deficiency Have Increased NETosis, Possibly Mediated by Reduced Levels of Circulating Activated Protein C

ISTH Academy, Faculty / Presenters, 406149

OC 74.3 Anticoagulant Use and Prognosis in Patients with Atrial Fibrillation and Cancer: A Nationwide Population-Based Study

ISTH Academy, Faculty / Presenters, 406111

OC 73.5 Delineating the Role of Physiologic Ligands on FVIIIa Inactivation

ISTH Academy, Faculty / Presenters, 406147

OC 62.2 Antiplatelet and Anticoagulant Compound (APAC) Restricts Thromboinflammation to Ameliorates Myocardial Ischemia Reperfusion Injury

ISTH Academy, Faculty / Presenters, 406148